Clinical Trials Directory

Trials / Unknown

UnknownNCT05859503

A Comparison Study of the Perclose Proglide (TM) SMC System Versus Figure-of-8- Suture Technique for Closure of Large-bore Femoral Venous Access.

A Comparison Study of the Perclose Proglide (TM) SMC System Versus Figure-of-8- Suture Technique for Closure of Large-bore Femoral Venous Access. (PERCLOSE-PROGLIDE)

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Hospital Universitari Vall d'Hebron Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to compare the efficacy and safety of two strategies for closing large caliber venous access in patients undergoing percutaneous procedures: compression with figure-of-8 suture versus closure with the Perclose-Proglide system.

Detailed description

This is a retrospective observational study that aims to compare two strategies for closing large-caliber femoral venous access in patients who have undergone percutaneous procedures. The study's goal is to determine if there are significant differences in terms of efficacy and safety between the two closure strategies. Figure-of-8 suture compression is a well-established technique that has been used for decades to close large-bore femoral venous access, while the Perclose-Proglide system is a relatively new medical device that could have great utility for the closure of large-bore femoral venous access. By comparing these two strategies, researchers hope to determine the safety and effectiveness of the Perclose-Proglide system for closing large-bore femoral venous access in patients undergoing percutaneous procedures.

Conditions

Interventions

TypeNameDescription
OTHERClosure Strategy with Perclose-Proglide systemPatients who have required Perclose-Proglide system in Percutaneous Interventional Procedure
OTHERClosure Strategy with figure-of-8Patients who have required the manual compression with figure-of-8 in Percutaneous Interventional Procedure

Timeline

Start date
2023-05-16
Primary completion
2023-09-01
Completion
2023-09-01
First posted
2023-05-16
Last updated
2023-05-17

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05859503. Inclusion in this directory is not an endorsement.